Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study

被引:0
|
作者
Saxena, Amit [1 ]
Caster, Dawn [2 ]
Almaani, Salem [3 ]
Rosales, Amber [4 ]
Leher, Henry [4 ]
机构
[1] NYU, Sch Med, New York, NY USA
[2] Univ Louisville, Louisville, KY USA
[3] Ohio State Univ, Med Ctr, Columbus, OH USA
[4] Aurinia Pharmaceut Inc, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0355
引用
收藏
页码:704 / 706
页数:3
相关论文
共 50 条
  • [1] Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study
    Caster, Dawn J.
    Saxena, Amit
    Almaani, Salem
    Rosales, Amber
    Leher, Henry
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 498 - 498
  • [2] VOCLOSPORIN FOR LUPUS NEPHRITIS: RESULTS OF THE TWO-YEAR AURORA 2 CONTINUATION STUDY
    Teng, Y. K. O.
    Saxena, Amit
    Palmen, Mary
    Birardi, Vanessa
    Lisk, Laura
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I819 - I820
  • [3] VOCLOSPORIN FOR LUPUS NEPHRITIS: RESULTS OF THE TWO-YEAR AURORA 2 CONTINUATION STUDY
    Saxena, A.
    Teng, Y. K. O.
    Collins, C.
    England, N.
    Leher, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 325 - 325
  • [4] Long-termSafety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies
    Contreras, Gabriel
    Baker, Matt
    Hodge, Lucy
    Yap, Ernie
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2971 - 2971
  • [5] Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial
    Saxena, Amit
    Ginzler, Ellen M.
    Gibson, Keisha
    Satirapoj, Bancha
    Santillan, Adolfina Elizabeth Zuta
    Levchenko, Olena
    Navarra, Sandra
    Atsumi, Tatsuya
    Yasuda, Shinsuke
    Chavez-Perez, Nilmo Noel
    Arriens, Cristina
    Parikh, Samir V.
    Caster, Dawn J.
    Birardi, Vanessa
    Randhawa, Simrat
    Lisk, Laura
    Huizinga, Robert B.
    Teng, Y. K. Onno
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (01) : 59 - 67
  • [6] Long-Term Safety and Efficacy of Voclosporin in Patients With Lupus Nephritis and Low eGFR
    Saxena, Ramesh
    Collins, Christopher E.
    Birardi, Vanessa
    Pavlova-Wolf, Anna
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 184 - 185
  • [7] Long-term Safety and Efficacy of Voclosporin in Hispanic and Latino Patients with Lupus Nephritis
    Ginzler, Ellen M.
    Saxena, Amit
    Bal, Victoria
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 710 - 712
  • [8] VOCLOSPORIN FOR LUPUS NEPHRITIS: INTERIM ANALYSIS OF THE AURORA 2 EXTENSION STUDY
    Saxena, A.
    Mina-Osorio, P.
    Mela, C.
    Berardi, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 585 - 586
  • [9] Voclosporin for Lupus Nephritis: Interim Analysis of the AURORA 2 Extension Study
    Saxena, Amit
    Mela, Christopher
    Coeshall, Antonia
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2990 - 2993
  • [10] Paired Kidney Biopsies from the AURORA 2 Study of Voclosporin in Active Lupus Nephritis
    Parikh, Samir
    Almaani, Salem
    Arazi, Arnon
    Song, Huijuan
    Yan, Pearlly
    Puchulu-Campanella, Estela
    Abner, Clint
    Yap, Ernie
    Piper, Krista
    Huizinga, Robert B.
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4650 - 4651